New technology to measure molecular interactions in cancer research.
Official title: Quantification of molecular interactions across the matrix spectrum enables cancer research.
Funded at Vanderbilt University · NIH-10918535 · Data updated 2026-11-12
This study is testing a new technology that helps scientists better understand how molecules interact in cancer, which could lead to earlier detection and better treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project start | September 1, 2024 |
| Project end | August 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $335,944 |
| NIH project number | 1R33CA291185-01 |
| Project ID | NIH-10918535 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with various types of cancer who may benefit from enhanced diagnostic techniques.
✕Less likely to help
Patients with non-cancerous conditions or those not seeking cancer-related diagnostic advancements may not receive benefits from this research.
What this research studies
This research focuses on developing a novel technology called free-solution assay (FSA) combined with a compensated Interferometric reader (CIR) to study molecular interactions in cancer. The approach is unique as it allows for ultra-sensitive, label-free measurements in various biological matrices without the need for enzyme-based methods. By refining this technology, researchers aim to enhance the understanding of cancer biology, improve early detection, and facilitate the discovery of biomarkers. Patients may benefit from advancements in clinical diagnosis and treatment strategies derived from this innovative methodology.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer detection and more effective treatment options for patients.
How similar studies have gone: Other research has shown promise with similar label-free technologies in cancer diagnostics, indicating potential for success in this novel approach.
Where this research is happening
-
Vanderbilt University
Nashville, United States Active
Researchers
- Principal investigator: Bornhop, Darryl J. — Vanderbilt University
- Study coordinator: Bornhop, Darryl J.
Related research
Other NIH-funded projects on the same topics.
-
Understanding how peer norms around alcohol and HIV prevention affect adolescents and young adults in rural Uganda
This project studies how what young people think their peers do or approve of influences drinking and HIV prevention behaviors in rural Uganda, with the goal of improving health outcomes.
-
Cancer Pain Management for Asian American Breast Cancer Survivors with Depressive Symptoms
A technology-based program helps Asian American breast cancer survivors with depressive symptoms manage chronic pain more effectively from home using a web app and mobile tools.
-
Targeted gene silencing in the brain using siRNA helpers
This grant tests a new way to turn off specific brain genes in particular CNS cell types using siRNA conjugates to help understand brain biology and disease.
-
RSELVES Study: How older couples influence daily life and function with Alzheimer’s risk
A study to understand how daily routines and support between older adults and their partners relate to the development of Alzheimer’s-related functional decline.
-
Molecular mechanisms of coat assembly and regulation in membrane trafficking
A research project seeks to understand how cellular coats organize and regulate the delivery of membrane-bound cargo, with a focus on proteins related to neurological diseases.
-
Synaptic nanostructure in neurodevelopmental disorders
This project aims to map the tiny architecture of brain synapses in native cells to understand how connections form and change in neurodevelopmental disorders.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.